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ABSTRACT
Objective. To determine the florfenicol concentration in bovine milk after intramuscular or
intramammary administration to establish the optimum withdrawal time, therapeutic efficacy,
and its influence on milk yield. Materials and method. Twelve healthy lactating Holstein
cows were selected from the University of Antioquia’s teaching dairy herd (Colombia), were
randomly assigned to a control (n=6) group or florfenicol (n=6) group that received 20 mg/kg
of florfenicol by intramammary and intramuscular routes, with a 15 days washout period
between treatments. Results. The Tmax and Cmax for the intramuscular route were 6 hours
and 2.86 mg/L respectively. The Tmax and Cmax for the intramammary route, were estimated
at 0 hour and about 20000 mg/L respectively by extrapolated from regression line. The
florfenicol elimination phase in milk had an average half-life of elimination (t½) of 19.8 hours
and 4.9 hours for intramuscular and intramammary administration, respectively. The therapeutic
efficacy only was reached by intramammary route, when minimal inhibitory concentration
(M.I.C.) of florfenicol by Stahphylococcus aureus, was used as reference value. There was
no statistically significant difference in milk yield between treated and non-treated cows.
Conclusions. According to these results, post-treatment milk withdrawal should be no less
than 3 days for intramammary administration, and at least 7 days for intramuscular
administration. The therapeutic efficacy only was reached by intramammary route. In addition,
there was no statistically significant difference in milk yield between treated and non-
treated cows.
Key words: Pharmacokinetics, residues, tolerance, cows, florfenicol.
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RESUMEN
Objetivo. Determinar la concentración de florfenicol en leche bovina después del tratamiento
intramuscular o intramamario, para establecer el tiempo de retiro, la eficacia terapéutica, y
su influencia sobre la producción láctea. Materiales y métodos. Se seleccionaron doce
vacas Holstein en lactancia de la hacienda de Universidad de Antioquia (Colombia). Se
asignaron al azar al grupo control (n=6) o al grupo florfenicol (n=6), al cual se le administró
20 mg/kg de florfenicol por vía intramamaria e intramuscular con 15 días de diferencia entre
tratamientos. Resultados. La Tmax  y Cmax para la vía intramuscular fueron 6 horas y 2.86
mg/L respectivamente. La Tmax y Cmax para la vía intramamaria, fueron estimados como 0
hora y aproximadamente 20000 mg/L respectivamente por extrapolación de la línea de
regresión. La fase de eliminación del florfenicol en leche, tuvo una vida media de eliminación
(t½)  promedio de 19.8 horas y 4.9 horas para la vía intramuscular e intramamaria
respectivamente. Cuando la concentración inhibitoria minima (C.I.M) del florfenicol para
Stahphylococcus aureus, fue usada como el valor de referencia, la eficacia terapéutica sólo
se alcanzó por la vía intramamaria. No existió diferencia estadística significativa entre las
producciones lácteas de las vacas tratadas y no tratadas. Conclusiones. De acuerdo con
estos resultados, el tiempo de retiro postratamiento no debe ser menor de 3 días para la
administración intramamaria y al menos 7 días para la administración intramuscular. La eficacia
terapéutica sólo se alcanzó por la vía intramamaria. Además no existió diferencia estadística
significativa en la producción láctea de las vacas tratadas con respecto a las no tratadas.
Palabras clave: Farmacocinética, residuos, tolerancia, vacas, florfenicol.
INTRODUCTION
The presence of antibiotic residues in milk
is an undesirable consequence of
antibacterial treatments in lactating dairy
cow(1). These residues could represent a
threat for animal and public health, due to
potential emergence of multidrug resistant
bacteria  (2,3).
The antibiotic florfenicol has entered the
veterinary world market, with high efficacy
for the treatment of bovine respiratory
disease (4). It belongs to the same
pharmacological group as chloramphenicol,
which has been withdrawn from the market
in many countries, while its use in others is
limited because of the possibility of generating
aplastic anemia in humans. Florfenicol (d-tre-
2,2-dichloro-N-c-a- (fluoromethyl)-b-
hydroxy-p-(phenethyl)acetamide), unlike
chloramphenicol and tiamphenicol, has a
fluorine atom instead of a hydroxyl group at
C3, which makes it resistant to deactivation
by transmissible plasmids of bacteria. It also
has a methylsulphonyl group instead of the
nitro group in chloranphenicol which is
responsible for generating aplastic anemia
in humans (5,6). Florfenicol has been
approved for veterinary but not for human
use (7).
Florfenicol, administered by intramuscular
and intramammary routes, has good
distribution in the bovine mammary gland
(8,9). In addition, the bacterium
Staphylococcus aureus has shown high
susceptibility to phenicols (10,11) making
florfenicol a good therapeutic option in S.
aureus caused mastitis (12).
In a study carried out by Otero et al (12),
it was shown that the volume distribution
for florfenicol is low (Vd=0.47±0.1 L/Kg), in
comparison to those of chloramphenicol in
bovines, which suggests a greater molecular
polarity due to replacing the nitro group by
the methylsulphonyl. This value is similar to
that reported by Soback et al (8) in 1995
(Vd=0.35±0.1 L/Kg), who administered
florfenicol at a dose of 20 mg/Kg, indicating
its distribution mainly in extracellular fluid.
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These results for volume distribution (Vd)
contrast with the report by Varma et al (9)
in 1986, and Adams et al (13) in 1987, who
found 0.78 L/Kg (at a dose of 22 mg/Kg
I.V.) and 0.872 L/Kg (at a dose of 11 mg/Kg
I.V.) respectively (9,13). Another study in
sheep in 2004 found Vd=0.55L/Kg (14).
These Vds could indicate a good milk
excretion.
The Non-observed Effect Levels (NOEL) for
florfenicol based on reproductive studies in
two generations was established at 1mg/
Kg/day (15). For estimating the Admissible
Daily Intake  (ADI)  a safety factor of 100
was used, which determined an ADI of 0.01
mg/Kg or 0.6 mg/person of 60 Kg of weight
in average (16), or Theoretical Maximum
Daily Intake  (TMDI)  (17). The TMDI divided
by the consumption factor of the different
animal tissues determines the Tol (Tolerance
Levels) for the United States, and Maximum
Residues Level (MRL) outside the United
States (18). Although maximum permissible
levels have not been established by the FDA
for florfenicol, some studies suggest that
the maximum provisional acceptable residues
of florfenicol in milk could be approximately
in a range between 0.08 and 0.2 mg/L, which
means that a provisional acceptable
tolerance level for florfenicol in milk, would
be in a concentration range between 0.048
and 1.22 mg/L (17). This represents a
possible target concentration for calculating
extralabel withdrawal times for florfenicol in
lactating cows.
The objective of the present work was to
determine the concentrations of florfenicol
in bovine milk after intramuscular or
intramammary administration, to propose
optimum withdrawal time for milk from
treated cows, its possible therapeutic
efficacy and its influence on milk yield.
MATERIALS AND METHODS
This work was done in compliance with the
animal protection law 84 of 1989 for the
Republic of Colombia.
Experimental population. Twelve healthy
lactating Holstein cows were selected from
the University of Antioquia teaching dairy
herd located in the township of San Pedro
de los Milagros, Colombia at 2.360 meters
of altitude with an average temperature of
16ºC. The cows were on pasture, grazing
on Kikuyo (Pennisetum clandestinum) fields.
A general clinical and mammary gland
examination was conducted on the selected
cows. Twelve lactating cows were randomly
assigned to treatment protocol with
florfenicol (n=6) with an interval of 15 days
between intrammamary or intramuscular
treatments, or to the control group (n=6).
Exclusion criteria. Dry cows (that are not
in milking) and sick animals (through
veterinary medical examination) were
excluded from the trial. Cows having at least
one of the following conditions were also
excluded: first lactation, more than three
parturitions, less than one month of
lactation, more than seven months of
lactation, abnormal mammary gland; and the
presence of clinical (medical examination)
or subclinical (according to CMT results)
mastitis.
Clinical examination of the mammary
gland. Mammary gland examination was
conducted in order to detect abnormal
mammary gland. It was assigned values
according to following scale, 0=soft
consistency, 1=any hard consistency,
parenchyma alteration, inflammation or
edema. Cows with the values different of
zero were excluded.
Evaluation of subclinical mastitis
(California Mastitis Test). Once the
mammary gland was evaluated, milk was
submitted to a semi-quantification of
somatic cells using the CMT (California
Mastitis Test) in order to exclude cows
suffering subclinical mastitis. The CMT
results were assessed in a scale of zero to
five, according to reaction type. Each
reaction type corresponds to an average
cell count, within a probable ranking (19).
Cows with the values different of zero were
excluded.
Allocation to treatment groups. Once the
cows were selected, after submitting them
to the exclusion criteria, treatment 1 was
carried out and, after 15 days of this
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treatment, they were subjected to
treatment 2.
Treatment group 1. Six cows were
subjected to an intramuscular application
of florfenicol in a 30% solution (Nuflor®
Schering Plough)  at a dose of 20 mg/Kg of
body weight, which is equivalent to 1 mL
per each 15 Kg of body weight.
Treatment group 2. Fifteen days after
treatment 1, the same six cows were
subjected to an intramammary application
of a 30% solution of florfenicol (Nuflor®
Schering Plough) at a dose of 20 mg/Kg of
body weight, which is equivalent to 1 mL
per each 15 Kg of weight. The total dose
was divided in four aliquots that were
administered in each one of the teats.
Control treatment. Six cows that fit the
same criteria of selection as the cows of
the experimental group were left without
treatment, but daily milk yield (liters) was
measured.
Procedure to obtain milk samples. The
cows were milked in a milking room using a
milking machine for 4 animals. Disinfection
of each nipple was done before and after
milking with a commercial iodine solution
(povidone). The daily milk yield of each cow
treated with florfenicol, and that of its
respective control cow were appropriately
registered from the day prior to the
treatment and during 7 days following
treatment.
Milk samples of cows treated with florfenicol
were taken in each of the two groups at
the following intervals: 0 hours and at 0.5,
1, 2, 3, 4, 6, 8, 24, 33, 48, 57, 72, 96, 120,
168, and 216 hours after intramuscular or
intramammary administration. Approximately
6 ml of milk from each quarter were collected
in the same glass bottles and transported
refrigerated (at 4ºC) to the laboratory for
residue analysis. They were then stored at
0ºC before processing within 24 hours.
Florfenicol assay. The analytical method
proposed by Pfenning was used (20). A
description of the extraction and validation
of analytical method in our laboratory is
further detailed elsewhere (21). The
validation of the Gas Chromatography (GC)
method was performed to determine
florfenicol in bovine milk in a concentration
range between 0.1 and 3.5 mg/L. The limit
of detection of this assay was 0.1 mg/L.
Precision, measured as the coefficient of
variation (CV), showed results between 12
and 16% in the lower concentrations of the
evaluated range; whereas in the high
concentrations, the CV was lower than 6%.
The accuracy and recovery showed that
the lowest concentration level of florfenicol,
0.1 mg/L, had the highest recovery
percentage (146.4%), and a CV of 13.4%.
Concentrations higher than 0.1 and lower
than 3.5 mg/L resulted in percentages of
recovery that varied between 99 and 107%
and CV between 4.92% and 8.71% (21).
Florfenicol quantification was conducted on
each of the samples obtained.
Data analysis. An univariate descriptive
analysis logarithmic regression and simple
linear model as well as comparative tests of
MANN WHITNEY and Pharmacokinetic
analysis with the PK Solution software®
were used for each treatment route.
The approximation at withdrawal time for
milk in florfenicol treated cows was
calculated, from
Δt = Ln (Ct / Ci) /λz (Eqn 1)
Where Dt is the time taken to go from Ci to
Ct; Ct is tolerance concentration and is
assumed to be 0.01 mg/L, since the maximum
concentration of florfenicol allowed in food
is zero. Some studies based on toxicological
research have reported that a provisory
tolerance florfenicol level in milk, should be
in a concentration range between 0.048 and
1.22 mg/L (17). The Ci (starting
concentration) is the florfenicol
concentration in milk in intercept of
elimination phase after intramuscular or
intramammary administration.
T½ (half life of elimination): Time required
to decrease the concentration of the drug
in milk by one half and λz is the constant
elimination rate (0.693/ T ½).
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The results of the ANOVA analysis of one
way of the dairy production of the six Holstein
cows treated with florfenicol by
intramuscular and intramammary routes and
their respective controls were carried out
with STATGRAPHICS version 4.1 software.
RESULTS
The average age and weight of the six cows
in the study was 4.5 years (range: 3.33-
5.42 years) and 575 kg (range: 480-615
kg), respectively. Cows were in their second
and third lactation with an average of 163.5
lactation days (range: 130-210 days). Two
of the cows had a pregnancy of less than 1
month and the four remaining cows were
not pregnant. The average body score was
2.6 (range: 2.25-3.0; scale from 1 to 5). All
of them presented a normal mammary gland
and negative CMT test. The cows were
pasturing on strips of Kikuyo prairie
(Penisetum clandestinum) with water at
libitum. The cows were milked at 7 a.m.
and at 3 p.m. on the first treatment day,
and at 7:00 a.m. and at 4:00 p.m. in the
days following the treatment.
A control cow (without florfenicol treatment
and in comparable reproductive and
productive conditions) was assigned to each
of the treated cows, of which florfenicol
concentrations were measured at hour 0
(zero). These data served as external
control, and guaranteed that there were no
other florfenicol sources in the production
lot apart from the treatment.
The profile of florfenicol concentrations in
the milk of six Holstein dairy lactating cows
treated by the intramuscular route at 20
mg/Kg is shown in figure 1. The florfenicol
concentrations in milk after intramuscular
administration are considered to fit a
monocompartmental linear regression
models, established in the program PK
Solution®, according to the slope seen in
figure 1.
A Cmax of 2.86 mg/L was attained 6 hours
after intramuscular administration. The
absorption phase is assumed up to that
moment.
The florfenicol elimination phase in milk after
florfenicol intramuscular administration (20
mg/Kg) was calculated between hours 8 and
120 post-administration as show in figure
1. The results from the regression analysis
have a regression coefficient of 0.99, and
an average half life of elimination (t½) of
19.8 hours, (Table 1); and an intercept of
2.98 mg/L.
Applying equation (1), and assuming that
Ct: (0.01 mg/L), Ci: (intercept elimination
phase 2.98 mg/L), T½ of 19.8 hours,
resulted in a 162.57 hours (6.77 days)
withdrawal time approximately, (Table 1).
Figure 1. The florfenicol concentrations in the milk
of six Holstein lactating cows treated
IMM or IM route in a dose of 20 mg/Kg
and comparison with MIC for
Staphylococcus aureus. It was assigned
the positive efficacy value to any
florfenicol concentration in milk, equal or
higher to 4 μg/mL (date from Otero et
al (12)). I.M: intramuscular, I.M.M:
Intramammary, M.I.C:Minimun inhibitory
concentrations.
Table 1. Pharmacokinetic parameters determined
in milk after intramuscular (I.M) and
intramammary (I.M.M.) administration of
florfenicol at dose of 20 mg/kg to six
Holstein lactating cows.
* The theoretical concentrations was calculated from
extrapolation of the linear regression analysis to time
zero.
Ruiz - Flornicol concentrations in milk of lactating cows
REVISTA MVZ CÓRDOBA  •  Volumen 15(2), Mayo - Agosto 20102046
 The results calculated by a previous method
were similar with dates experimental,
because, after intramuscular administration
the levels of florfenicol in the milk on the
end day of study 7 were under of 0.1 mg/L
(detection level).
The profile of florfenicol concentrations in
the milk of the six cows, treated
intramammary route at 20 mg/Kg is shown
in figure 1. The florfenicol concentrations in
milk after intramammary administration are
considered to fit a three-compartmental
nonlinear regression models, established in
the program PK Solution®, according to the
slope seen in figure 1.
The possible free passage of florfenicol from
milk to systemic circulation can occur from
minute 30 to minute 120 post-administration,
as shown in figure 1. The pharmacokinetic
regression analysis model gave a correlation
coefficient of 0.99; an average absorption
life of 21.15 minutes, and an intercept of
20093.41 μg/mL (concentration at zero
minute). The intercept indicates the
florfenicol concentration at 0 hour (zero).
The absorption-distribution phase
corresponds to the time range between
hours 3 and 8 post-administration as seen
in figure 1. The pharmacokinetic regression
analysis model gave a correlation coefficient
of 0.98; an absorption half-life of 1.76 hours.
The elimination phase, takes place between
hours 24 and 72, as seen in figure 1. As a
result, the regression analysis indicated a
correlation coefficient of 0.97; an average
elimination half-life of 4.92 hours, and an
intercept of 132.07 mg/L.
Applying equation (1), and assuming that
Ct: (0.01 mg/L), Ci: (intercept elimination
phase 132.07 mg/L), T½ of 4.92 hours,
resulted in a 67.3 hours (2.8 days)
withdrawal time.
The results calculated by the previous
method are similar from the experimental
data, in which it was established that the
approximate withdrawal time of milk in cows
treated with florfenicol by intramammary
route, was 72 hours (3 days).
The results show, by comparison of the
average and variances for the hypothesis
test, that there are significant differences
for florfenicol concentrations both between
the intramuscular and intramammary routes
of administration (p<0.01).
In this study florfenicol concentrations equal
or higher to 4 μg/mL were considered
effective, which is the minimum inhibitory
concentration reported by Otero et al for
the Staphylococcus aureus. Otero et al (12)
evaluated 25 strains of aureus isolated from
clinical and subclinical mastitis to determine
MIC. For this, a range of concentrations of
florfenicol from 0.125 and to 128 mg/ml was
used. The florfenicol MIC for 24 strains in
the study oscillated between 4 and 8 mg/
mL which are considered normal for this kind
of germ. These data are useful for evaluating
the efficiency of florfenicol in the bovine
mammary gland.
Thus, the positive efficiency value for any
florfenicol concentration in milk was
considered equal or higher to 4 μg/mL, and
the variable efficiency was negative when
the concentration was lower than the value
mentioned (Figure 1).
Figure 1 shows that the only route of
administration that reaches the efficiency
level is the intramammary route and,
specifically, during the time between zero
(moment of administration) and 8 hours (prior
to the first milking post-treatment). For the
intramuscular treatment, the efficiency is
considered negative since, from the first
post-treatment hours, it had not reached
concentrations equal or higher to the MIC
(4 μg/mL) reported for the Staphylococcus
aureus (12).
Concerning the production of milk in cattle
lots treated with florfenicol by intramuscular
route, an average dairy production of 13.6
liters for seven days during the evaluation
and 13.98 liters for the control cows was
obtained, without a statistically significant
difference (p>0.05). Milk yield of the cows
treated with florfenicol by the intramammary
route was approximately 14.28 liters for the
seven days of evaluation and 14.82 liters
of milk for control cows during the same
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evaluation period with no statistically
significant difference (p>0.05). This shows
that there is no statistically significant
difference in the milk production between
the cows treated by either intramuscular or
intramammary route and their respective
controls (p>0.05).
DISCUSSION
In this work, the study of intramuscular
administration of florfenicol demonstrated
that after 30 minutes there are quantifiable
florfenicol concentrations above 0.13 mg/
L. These results contrast with those
reported by Soback et al (8) in 1995, who,
after 30 minutes, could not find florfenicol in
quantifiable quantities in milk. This could be
explained by the fact that his analytic
technique allowed the quantification of a level
of 0.5 mg/L florfenicol in milk, whereas in this
study the quantifiable limit was 0.1 mg/L.
Regarding the maximum of florfenicol
concentrations in milk after intramuscular
treatment, these were reached at 6 hours
with an average of 2.86 μg/mL, which does
not differ statistically from the concentration
of 2.75 μg/mL, obtained at 8 hours prior to
the afternoon milking (first post-treatment
milking). Soback et al (8) reported a maximal
concentration of 1.6 μg/mL, obtained at 12
hours. In agreement with the study by
Sobacks et al (8), our results show a
common pharmacokinetic behavior pattern
in which florfenicol is accumulated in the
bovine mammary gland and reaches a
maximum concentration in the milk just
before the first post-intervention milking,
which in this case was at 8 hours post-
treatment, whereas it was at 12 hours in
the study by Soback el al (8).
After the first milking, the concentrations
of florfenicol decreased until an average of
1.213 μg/mL, 24 hours after intramuscular
post-administration (before the second
milking), which is equal to less than half of
the level obtained before the first milking.
This relation was also observed in the study
by Soback et al (8), although in his case
the average concentration was 0.6 μg/mL.
The levels of florfenicol in milk between 33
and 120 hours (5 days) after intramuscular
treatment are lower than 1 μg/mL, as
detectable by the analytical technique used.
This establishes a non-useful therapeutic
quantity for infections of treatment in the
bovine mammary gland that is non regular
regarding residues of this antibiotic in milk
as established by the FDA.
Soback et al (8) maintains in his study, that
after 48 hours of an intramuscular
administration, florfenicol concentrations in
milk are 0 μg/mL. However, the analytic
technique used in this study allows
quantification of lower concentrations than
those detected by Soback et al (8). We
consider this to be the reason for finding
quantifiable levels of florfenicol in milk for a
longer time period.
After treatment with florfenicol at a dose
of 20 mg/kg by intramammary route,
concentrations in milk at 30 minutes reached
an average of 12.5±2.9 mg/mL. These data
surpassed previous works by up to 12 fold
the level reported by Soback et al (8). The
results of this work can be explained if we
take into account that average
administration of florfenicol at 30% by
quarter was 9.56 mL, which corresponds to
a dose of 2.868 grams (2.868.000 mg) by
quarter. It is inferred that at zero minute
before the absorption process of florfenicol
from the mammary gland towards the
systemic blood system, concentrations of
florfenicol were approximately 2009 3 mg/L
(according to pharmacokinetics
calculations). Assuming complete distribution
of product in the volume of milk remaining
after each milking, when the intramammary
infusion was administrated, an estimated
volume of approximately 570 ml milk was
left in udder following the morning milkings.
It is observed from our results that 1 hour
after the intramammary administration, there
was a progressive decrease of florfenicol
levels in milk, which is similar to the data
obtained by Soback et al (8), although the
values found in this study are higher than
the ones described by him. At 8 hours prior
to the first milking, an average florfenicol
concentration in milk of 318.12 ± 129.62
mg/mL was found, while Soback et al (8)
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reported 202 ± 17g/mL at the same time.
Between 24 hours of administration of
florfenicol by intramammary route to 57
hours, quantifiable levels of florfenicol are
still found in milk, which differs from what
was found by Soback et al (8), who found
no florfenicol in milk at 48 hours, probably
because the concentrations in milk were
under the limit of detection allowed by his
analytical method.
The progressive decrease in levels of
florfenicol in milk after the intramammary
administration may possibly be due to the
following four factors: the absorption
process from the mammary gland to the
blood system, the dilution effect exerted
by milk production, its elimination from the
mammary gland by the excretion in milk, and
its metabolism “in situ”, for which, although
the values are unknown, should not be
discarded.
For intramuscular administration of
florfenicol, the decrease of florfenicol in milk,
after its distribution from the blood stream,
may be due mainly to the re-absorption from
the milk to the blood stream, the excretion
in milk itself and the metabolism “in situ”
into udder.
The analysis of the results poses questions
concerning two essential parameters used
to evaluate the performance of an antibiotic
in the mammary gland: first, the prediction
of the therapeutic efficiency and second,
the residual potential of any antibiotic that
reaches the mammary gland of cattle in the
process lactating.
Concerning the therapeutic efficiency, the
fundamental parameter for evaluation of this
aspect is the Minimum Inhibitory
Concentration (MIC) of the microorganism
or microorganisms to be controlled. As was
mentioned before, the most common
isolated germs of the bovine mammary gland
in several countries are Streptococcus and
Staphylococcus sp (22). Streptococcus
agalactiae is the most prevalent germ, which
shows good sensitivity to β-lactamic
antibiotics (23). Staphylococcus aureus is
the hardest bacteria to treat, due to its
resistances to antibiotics (22,24).
Therefore, in milk farms it is important to
apply new pharmaco-therapeutic
alternatives which show efficiency in the
treatment for aureus.
Concentrations of florfenicol in milk after a
20 mg/Kg intramuscular treatment are sub-
optimum for bacteria such as aureus isolated
from bovine mastitis, thus this route of
administration is not recommended for
treatment of mastitis. However middle
strains should be evaluated and it would be
better to determine the MIC in milk, which
is the medium in which the antibiotic would
act. This conclusion is in contrast to that
drawn by Otero et al (12), who considered
the plasmatic concentrations obtained by
florfenicol through the intramuscular route
to be efficient. However, they concluded
that the best parameter to evaluate
efficiency in this type of pathologies were
the concentrations of florfenicol in milk.
For the intramammary route, concentrations
are maintained above 4 μg/ml from 0 minute
to 480 minute after treatment, thus its effect
is expected all along that period. Soback et
al obtained a similar pharmacokinetic
behavior, showing that 20 mg/Kg of body
weight of florfenicol by intramammary route
reached concentrations above 4 μg/ml in
milk from the time of administration until 11
hours post-treatment.
Concerning the residues of florfenicol in milk,
the FDA (Foods and Drug Administration)
establishes that any quantity of florfenicol
in milk is considered as violative (7). Some
studies based on toxicological investigations,
have reported that a provisional tolerance
level of florfenicol in milk, would be in the
range of concentration between 0.048 and
1.22 mg/L (17).
If we assume that the concentration of 0.01
mg/L is the maximum allowed level of residues
of florfenicol in milk according to suggestions
of Baynes et al (17) withdrawal-time after
intramuscular treatment, should be probably
6.77 days and for the intramammary
treatment 2.8 days. These withdrawal-times
could be lower if a greater level of tolerance
of 0.10 mg/L is established.
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In conclusion the intramammary and
intramuscular florfenicol treatment in
lactating cows using 20 mg/Kg, produce
residues in milk.
Regarding the intramammary treatment, up
to concentrations 4 mg/mL are achieved by
its applications to the next milking (8 hours)
using a dose of 20 mg/Kg divided into every
quarter. Besides, persistency of residues in
milk using the intramammary treatment is
shorter by 4 days compared to the case of
the intramuscular treatment.
In this study the milk yield of treated groups
with florfenicol, as compared to their
controls without treatment, remained
unaltered.
Some recommendations, it is necessary to
undertake research on the residues and
persistency of diverse antibiotics in biological
fluids of livestock animals as a basis for the
pharmaco-epidemiologic follow-up of public
health problems that are both serious and
resistant, and the new re-emergence of
infections.
The efficiency of florfenicol can be
determined by theoretically pharmacokinetic
models. Therefore, is necessary to carry out
prior clinical trials.
In conclusion, according to these results,
post-treatment milk withdrawal should be no
less than 3 days for intramammary
administration, and at least 7 days for
intramuscular administration. The
therapeutic efficacy only was reached by
intramammary route. In addition there was
no statistically significant difference in milk
yield between treated and non-treated
cows.
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